TAVO™
Our lead product candidate is being evaluated in multiple cancer indications, including melanoma and TNBC.
LEARN MORE
Technology
Our plasmid DNA delivery platform is designed to boost the body’s immune system to target and attack cancer.
LEARN MORE
Publications
We are committed to sharing the results of our research and clinical development programs.
LEARN MORE